Breast cancer genome anatomy: correlation of morphological changes in breast carcinomas with expression of the novel gene product Di12

Burger, Angelika; Li, Hua; Zhang, Xian-Kui; Pienkowska, Malgorzata; Venanzoni, Marco; Vournakis, John; Papas, Takis; Seth, Arun
January 1998
Oncogene;1/22/98, Vol. 16 Issue 3, p327
Academic Journal
To determine which genes may be activated or inactivated during breast cancer development, we employed two cloning strategies (subtractive hybridization and differential display) using RNA samples from a human breast tumor and its matching normal breast cell line. Of 950 clones isolated, 102 cDNA inserts were analysed by DNA sequencing and database searching. We found 30 clones that were obviously unidentified, with no significant homology to any listed human gene. We focused upon one of the novel genes, Di12, that is differentially expressed as a 1.35 kb RNA in breast cancer tissues and cell-lines, and in several normal tissues. A full length cDNA of this gene was cloned, and its DNA sequence revealed an open reading frame of 339 amino acids. Antibodies to the ten N-terminal amino acids were developed to investigate the expression of Di12 in breast cancer cell-lines and tumors. The Di12 protein was found in tissue sections of infiltrating ductal carcinomas (IDCs), but not in benign or normal breast specimens. RT – PCR analysis confirmed expression of Di12 in 80% of infiltrating ductal carcinomas (IDCs). As IDC constitutes ∼70% of breast cancers seen clinically, the level of Di12 expression may be predictive of disease progression.


Related Articles

  • Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer. He Zhu; Bhaijee, Feriyl; Ishaq, Nivin; Pepper, Dominique J.; Backus, Kandis; Brown, Alexandra S.; Xinchun Zhou; Miele, Lucio // American Journal of Cancer Research;2013, Vol. 3 Issue 2, p230 

    Gene expression profiling reveals elevated Notch1 mRNA expression in triple negative breast cancers (TNBC), both basaloid and claudin-low subtypes. Notch ligands, Jagged1 and Jagged2, have been correlated with poor prognosis in TNBC. AKT, an oncogenic protein kinase family that is activated...

  • RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway. Xiang Zhang; Jie Min; Yingjian Wang; Yan Li; Hongzhong Li; Qiang Liu; Xinjie Liang; Peng Mu; Hongyuan Li // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background: RABEX-5, a guanine nucleotide exchange factor (GEF) for RAB-5, plays an important role in cell mobility and altered expression associated with tumor metastasis. This study aimed to investigate the role of RABEX-5 in proliferation and metastasis of breast cancer in vitro and ex vivo....

  • Mammaglobin: A novel tumor marker for breast cancer. El-Sharkawy, Sonia Labib; El-Aal, Wafaa El Saied Abd; El-Shaer, Marwa Abd El Monaem; Abbas, Naglaa Fathy; Youssef, Mona Fathy // Turkish Journal of Cancer;Jul2007, Vol. 37 Issue 3, p89 

    Breast cancer is a major problem among females all over the world. Despite apparent curative resection, subsequent development of metastatic spread presents a major clinical problem in about 30% of all breast cancer patients. The aim of this study was to investigate the clinical reliability of...

  • A Splice Variant of HER2 Corresponding to Herstatin Is Expressed in the Noncancerous Breast and in Breast Carcinomas. Koletsa, Triantafyllia; Kostopoulos, Ioannis; Charalambous, Elpida; Christoforidou, Barbara; Nenopoulou, Eleni; Kotoula, Vassiliki // Neoplasia;Jul2008, Vol. 10 Issue 7, p687 

    Herstatin (HST) is an alternatively spliced HER2 product with growth-inhibitory properties in experimental cancer systems. The role of HST in adult human tissues and disease remains unexplored. Here, we investigated HST expression at the mRNA and protein (immunohistochemistry [IHC]) level in...

  • B7-H3 expression in breast cancer and upregulation of VEGF through gene silence. Jing Sun; Yun-Di Guo; Xiao-Ning Li; Yang-Qin Zhang; Li Gu; Ping-Ping Wu; Guang-Hui Bai; Yang Xiao // OncoTargets & Therapy;2014, Vol. 7, p1979 

    B7-H3, a novel member of the B7 family, was previously known as a regulatory ligand regulating T-cell-mediated immune response, and in recent years it was found to take a significant role in various cancers. In some tumor types, high expression of B7-H3 had been linked to a poor prognosis,...

  • The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer. Wortham, N. C.; Ahamed, E.; Nicol, S. M.; Thomas, R. S.; Periyasamy, M.; Jiang, J.; Ochocka, A. M.; Shousha, S.; Huson, L.; Bray, S. E.; Coombes, R. C.; Ali, S.; Fuller-Pace, F. V. // Oncogene;11/19/2009, Vol. 28 Issue 46, p4053 

    The DEAD-box RNA helicases p68 (DDX5) and p72 (DDX17) have been shown to act as transcriptional co-activators for a diverse range of transcription factors, including oestrogen receptor-α (ERα). Here, we show that, although both proteins interact with and co-activate ERα in reporter gene...

  • Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. D Treré; L Montanaro; C Ceccarelli; S Barbieri; G Cavrini; D Santini; M Taffurelli; M Derenzini // Annals of Oncology;Jun2007, Vol. 18 Issue 6, p1004 

    Background: Bcl2 is an important prognostic parameter in human breast cancer. However, the evaluation of Bcl2 expression by immunohistochemistry is carried out using arbitrary scoring criteria. In the present study, we evaluated the clinical relevance of a novel, semiquantitative classification...

  • Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. Loussouarn, D.; Campion, L.; Leclair, F.; Campone, M.; Charbonnel, C.; Ricolleau, G.; Gouraud, W.; Bataille, R.; Jézéquel, P.; Jézéquel, P // British Journal of Cancer;7/7/2009, Vol. 101 Issue 1, p166 

    Background: We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The aim of this study was to validate UBE2C protein as a prognostic marker in N+ breast cancer by immunohistochemistry...

  • Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer. Berdel, Bozena; Nieminen, Kaisa; Soini, Ylermi; Tengstr”m, Maria; Malinen, Marjo; Kosma, Veli-Matti; Palvimo, Jorma J.; Mannermaa, Arto // BMC Cancer;2012, Vol. 12 Issue 1, p516 

    Background: The histone demethylase GASC1 (JMJD2C) is an epigenetic factor suspected of involvement in development of different cancers, including breast cancer. It is thought to be overexpressed in the more aggressive breast cancer types based on mRNA expression studies on cell lines and meta...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics